elevated triglycerides
Showing 1 - 25 of 4,183
Hyperlipidemia Trial in Beijing (JS401, Placebo)
Recruiting
- Hyperlipidemia
- JS401
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 15, 2023
Cardiometabolic Syndrome, Dyslipidemias, Hypertension Trial in Wakiso (Tamarindus indica fruit juice)
Not yet recruiting
- Cardiometabolic Syndrome
- +2 more
- Tamarindus indica fruit juice
-
Wakiso, UgandaKajjansi HCIV
Sep 22, 2023
Elevated Triglycerides, Hypertriglyceridemia Trial in Chicago, Indianapolis (Average American Diet With SoFAS Replaced With
Recruiting
- Elevated Triglycerides
- Hypertriglyceridemia
- Average American Diet With SoFAS Replaced With Avocado
- Average American Diet
-
Chicago, Illinois
- +1 more
Mar 8, 2022
Elevated Triglycerides Trial in London, Toronto (GFA-918, Placebo)
Completed
- Elevated Triglycerides
- GFA-918
- Placebo
-
London, Ontario, Canada
- +1 more
Dec 21, 2021
Overweight and Obesity, Elevated Triglycerides Trial in Chicago, Gurnee (Full-fat fermented dairy, Low-fat fermented dairy,
Enrolling by invitation
- Overweight and Obesity
- Elevated Triglycerides
- Full-fat fermented dairy
- +2 more
-
Chicago, Illinois
- +2 more
Dec 9, 2022
Hypertriglyceridemia Trial in Leeds (NST-1024, Placebo)
Recruiting
- Hypertriglyceridemia
- NST-1024
- Placebo
-
Leeds, West Yorkshire, United KingdomCovance Leeds Clinical Research Unit
Mar 2, 2022
Hypertriglyceridemia, Familial Hypercholesterolemia Trial in Toronto (IONIS ANGPTL3-LRx, Placebo)
Completed
- Hypertriglyceridemia
- Familial Hypercholesterolemia
- IONIS ANGPTL3-LRx
- Placebo
-
Toronto, Ontario, CanadaClinical Site
Nov 17, 2020
Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule
Recruiting
- Cardiovascular Diseases
- +3 more
- Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
-
North York, Ontario, Canada
- +3 more
Nov 7, 2022
Acute Pancreatitis Trial in Ljubljana (plasma exchange, conservative treatment)
Completed
- Acute Pancreatitis
- plasma exchange
- conservative treatment
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana, Ljubljana, Slovenia
Nov 2, 2020
NASH Trial in China (chiglitazar sodium tablets, Placebo)
Recruiting
- NASH
- chiglitazar sodium tablets
- Placebo
-
Beijing, Beijing, China
- +14 more
Mar 22, 2022
Hypercholesterolemia, Hypertriglyceridemia Trial (Gemcabene 150 mg, Gemcabene 300 mg, Gemcabene 600 mg)
Completed
- Hypercholesterolemia
- Hypertriglyceridemia
- Gemcabene 150 mg
- +4 more
- (no location specified)
Apr 8, 2020
Elevated Triglycerides, Cardiovascular Risk Factor Trial in Tucson (DPA enriched n-3, n-3 control, Placebo)
Unknown status
- Elevated Triglycerides
- Cardiovascular Risk Factor
- DPA enriched n-3
- +2 more
-
Tucson, ArizonaUniversity of Arizona
Sep 11, 2019
Hypertriglyceridemia Trial in Cork (Placebo, Candida cylindracea lipase (225,000 FIP lipase units per day), Candida cylindracea
Completed
- Hypertriglyceridemia
- Placebo
- +3 more
-
Cork, Co. Cork, IrelandAtlantia Food Clinical Trials, Western Gateway Bldg, University
Mar 21, 2022
Knee Osteoarthritis, Cardiovascular Diseases Trial (High intensity exercise)
Not yet recruiting
- Knee Osteoarthritis
- Cardiovascular Diseases
- High intensity exercise
- (no location specified)
Mar 8, 2023
Elevated Triglycerides, Diabetes, Cardiovascular Disease Trial in New York (Fructose + Glucose Beverage)
Completed
- Elevated Triglycerides
- +3 more
- Fructose + Glucose Beverage
-
New York, New York
- +1 more
Jun 14, 2019
Hyperlipidemias, Hypercholesterolemia Trial in Chios (Chios Mastiha essential oil, Placebo)
Completed
- Hyperlipidemias
- Hypercholesterolemia
- Chios Mastiha essential oil
- Placebo
-
Chios, GreeceSkylitseio General Hospital
May 11, 2023
Primary Hypercholesterolemia or Mixed Dyslipidemia Trial (Inclisiran, Matching Placebo for Inclisiran)
Not yet recruiting
- Primary Hypercholesterolemia or Mixed Dyslipidemia
- Inclisiran
- Matching Placebo for Inclisiran
- (no location specified)
May 24, 2023
Mild-to-Moderate Obstructive Sleep Apnea: Inflammation vs.
Enrolling by invitation
- Obstructive Sleep Apnea
-
Hershey, PennsylvaniaPenn State College of Medicine, Penn State Milton S. Hershey Med
Jan 26, 2023
Generalized Lipodystrophy Trial in Worldwide (Placebo, Low-Dose REGN4461, High-dose REGN4461)
Active, not recruiting
- Generalized Lipodystrophy
- Placebo
- +2 more
-
Bethesda, Maryland
- +7 more
Mar 9, 2022
Type1diabetes, Fatty Liver Trial in Afula (liver elastography)
Enrolling by invitation
- Type1diabetes
- Fatty Liver
- liver elastography
-
Afula, Israel/zaphon, IsraelEmek Medical Center
Jul 3, 2023
Predictors of Metabolic Syndrome in Obese Child
Not yet recruiting
- Metabolic Disorders in Children
- Waist-height ratio
- +2 more
- (no location specified)
Jan 9, 2023
PCOS Trial (3-OHB (KE4), water)
Not yet recruiting
- PCOS
- 3-OHB (KE4)
- water
- (no location specified)
Mar 14, 2023